PPFIBP2 is a novel gene in the LAR protein-tyrosine phosphatase-interacting protein (liprin) family that has been reported to be an independent prognostic biomarker in prostate cancer and thyroid cancer (43, 44). This evidence concerns the gene PPFIBP2 and prostate carcinoma.